- Investigator
- Porter F Young
- Ages
- 60 Years - 85 Years
- Sexes
- All
Clinical trials
-
Double Blind Placebo-Controlled Parallel Group Study of Safety and Efficacy of Isomyosamine in Treating Sarcopenia After Hip or Femoral Fracture in Gerontological Population